메뉴 건너뛰기




Volumn 49, Issue 10, 2013, Pages 2403-2410

Time trends in survival from cancer of unknown primary: Small steps forward

Author keywords

Cancer of unknown primary; CUP; Survival; Trend

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BILIARY TRACT CANCER; CANCER LOCALIZATION; CANCER MORTALITY; CANCER OF UNKNOWN PRIMARY SITE; CANCER PROGNOSIS; CANCER SURVIVAL; CAUSE OF DEATH; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM TUMOR; OVARY CANCER; PELVIS CANCER; PERITONEUM CANCER; PRIORITY JOURNAL; SURVIVAL TIME; TREND STUDY;

EID: 84878395606     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.02.022     Document Type: Article
Times cited : (25)

References (38)
  • 1
    • 52449118245 scopus 로고    scopus 로고
    • Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary
    • H.M. Horlings, R.K. van Laar, and J.M. Kerst Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary J Clin Oncol 26 27 2008 4435 4441
    • (2008) J Clin Oncol , vol.26 , Issue.27 , pp. 4435-4441
    • Horlings, H.M.1    Van Laar, R.K.2    Kerst, J.M.3
  • 2
    • 84859625307 scopus 로고    scopus 로고
    • Cancer of unknown primary site
    • N. Pavlidis, and G. Pentheroudakis Cancer of unknown primary site Lancet 379 9824 2012 1428 1435
    • (2012) Lancet , vol.379 , Issue.9824 , pp. 1428-1435
    • Pavlidis, N.1    Pentheroudakis, G.2
  • 3
    • 84864323806 scopus 로고    scopus 로고
    • Survival in cancer of unknown primary site: Population-based analysis by site and histology
    • K. Hemminki, M. Bevier, A. Hemminki, and J. Sundquist Survival in cancer of unknown primary site: population-based analysis by site and histology Ann Oncol 23 7 2012 1854 1863
    • (2012) Ann Oncol , vol.23 , Issue.7 , pp. 1854-1863
    • Hemminki, K.1    Bevier, M.2    Hemminki, A.3    Sundquist, J.4
  • 4
    • 70350361222 scopus 로고    scopus 로고
    • Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: Multiple-treatments meta-analysis
    • V. Golfinopoulos, G. Pentheroudakis, G. Salanti, A.D. Nearchou, J.P.A. Ioannidis, and N. Pavlidis Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis Cancer Treat Rev 35 7 2009 570 573
    • (2009) Cancer Treat Rev , vol.35 , Issue.7 , pp. 570-573
    • Golfinopoulos, V.1    Pentheroudakis, G.2    Salanti, G.3    Nearchou, A.D.4    Ioannidis, J.P.A.5    Pavlidis, N.6
  • 5
    • 0346494939 scopus 로고    scopus 로고
    • Cancer of unknown primary: Clinicopathologic correlations
    • H. Blaszyk, A. Hartmann, and J. Bjornsson Cancer of unknown primary: clinicopathologic correlations APMIS 111 12 2003 1089 1094
    • (2003) APMIS , vol.111 , Issue.12 , pp. 1089-1094
    • Blaszyk, H.1    Hartmann, A.2    Bjornsson, J.3
  • 6
    • 0028241857 scopus 로고
    • Unknown primary carcinoma: Natural history and prognostic factors in 657 consecutive patients
    • J.L. Abbruzzese, M.C. Abbruzzese, K.R. Hess, M.N. Raber, R. Lenzi, and P. Frost Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients J Clin Oncol 12 6 1994 1272 1280
    • (1994) J Clin Oncol , vol.12 , Issue.6 , pp. 1272-1280
    • Abbruzzese, J.L.1    Abbruzzese, M.C.2    Hess, K.R.3    Raber, M.N.4    Lenzi, R.5    Frost, P.6
  • 7
    • 70350683800 scopus 로고    scopus 로고
    • Cancer patients without a known primary: Incidence and survival trends in Sweden 1960-2007
    • M. Randen, L.-E. Rutqvist, and H. Johansson Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007 Acta Oncol 48 6 2009 915 920
    • (2009) Acta Oncol , vol.48 , Issue.6 , pp. 915-920
    • Randen, M.1    Rutqvist, L.-E.2    Johansson, H.3
  • 8
    • 52449084470 scopus 로고    scopus 로고
    • Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation
    • G.R. Varadhachary, D. Talantov, and M.N. Raber Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation J Clin Oncol 26 27 2008 4442 4448
    • (2008) J Clin Oncol , vol.26 , Issue.27 , pp. 4442-4448
    • Varadhachary, G.R.1    Talantov, D.2    Raber, M.N.3
  • 9
    • 80052724384 scopus 로고    scopus 로고
    • Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    • K. Fizazi, F.A. Greco, N. Pavlidis, and G. Pentheroudakis Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 22 Suppl. 6 2011 vi64 vi68
    • (2011) Ann Oncol , vol.22 , Issue.SUPPL. 6
    • Fizazi, K.1    Greco, F.A.2    Pavlidis, N.3    Pentheroudakis, G.4
  • 10
    • 64049104974 scopus 로고    scopus 로고
    • Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: A systematic literature review
    • G. Pentheroudakis, F.A. Greco, and N. Pavlidis Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review Cancer Treat Rev 35 3 2009 221 227
    • (2009) Cancer Treat Rev , vol.35 , Issue.3 , pp. 221-227
    • Pentheroudakis, G.1    Greco, F.A.2    Pavlidis, N.3
  • 11
    • 84856339714 scopus 로고    scopus 로고
    • Cancer of unknown primary: Progress in the search for improved and rapid diagnosis leading toward superior patient outcomes
    • F.A. Greco, K. Oien, and M. Erlander Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes Ann Oncol 23 2 2011 298 304
    • (2011) Ann Oncol , vol.23 , Issue.2 , pp. 298-304
    • Greco, F.A.1    Oien, K.2    Erlander, M.3
  • 12
    • 84856071488 scopus 로고    scopus 로고
    • Cancers of unknown primary origin: Current perspectives and future therapeutic strategies
    • G. Stella, R. Senetta, A. Cassenti, M. Ronco, and P. Cassoni Cancers of unknown primary origin: current perspectives and future therapeutic strategies J Transl Med 10 1 2012 12
    • (2012) J Transl Med , vol.10 , Issue.1 , pp. 12
    • Stella, G.1    Senetta, R.2    Cassenti, A.3    Ronco, M.4    Cassoni, P.5
  • 13
    • 0036161957 scopus 로고    scopus 로고
    • Epidemiology of unknown primary tumours; Incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992
    • A.J. van de Wouw, M.L. Janssen-Heijnen, J.W. Coebergh, and H.F. Hillen Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992 Eur J Cancer 38 3 2002 409 413
    • (2002) Eur J Cancer , vol.38 , Issue.3 , pp. 409-413
    • Van De Wouw, A.J.1    Janssen-Heijnen, M.L.2    Coebergh, J.W.3    Hillen, H.F.4
  • 14
    • 84859424945 scopus 로고    scopus 로고
    • Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden
    • X. Shu, K. Sundquist, J. Sundquist, and K. Hemminki Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden Eur J Cancer Prev 21 3 2012 281 288
    • (2012) Eur J Cancer Prev , vol.21 , Issue.3 , pp. 281-288
    • Shu, X.1    Sundquist, K.2    Sundquist, J.3    Hemminki, K.4
  • 15
    • 84866976266 scopus 로고    scopus 로고
    • Incidence of cancer of unknown primary in Sweden: Analysis by location of metastasis
    • M. Bevier, J. Sundquist, and K. Hemminki Incidence of cancer of unknown primary in Sweden: analysis by location of metastasis Eur J Cancer Prev 21 6 2012 596 601
    • (2012) Eur J Cancer Prev , vol.21 , Issue.6 , pp. 596-601
    • Bevier, M.1    Sundquist, J.2    Hemminki, K.3
  • 16
    • 84863244155 scopus 로고    scopus 로고
    • Power and limits of modern cancer diagnostics: Cancer of unknown primary
    • K. Hemminki, H. Liu, A. Heminki, and J. Sundquist Power and limits of modern cancer diagnostics: cancer of unknown primary Ann Oncol 23 3 2011 760 764
    • (2011) Ann Oncol , vol.23 , Issue.3 , pp. 760-764
    • Hemminki, K.1    Liu, H.2    Heminki, A.3    Sundquist, J.4
  • 17
    • 77952840512 scopus 로고    scopus 로고
    • Trends in the survival of patients diagnosed with cancers in the respiratory system in the Nordic countries 1964-2003 followed up to the end of 2006
    • T. Hakulinen, G. Engholm, and M. Gislum Trends in the survival of patients diagnosed with cancers in the respiratory system in the Nordic countries 1964-2003 followed up to the end of 2006 Acta Oncol 49 5 2010 608 623
    • (2010) Acta Oncol , vol.49 , Issue.5 , pp. 608-623
    • Hakulinen, T.1    Engholm, G.2    Gislum, M.3
  • 18
    • 77952843979 scopus 로고    scopus 로고
    • Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964-2003 followed up to the end of 2006
    • Å. Klint, G. Engholm, and H.H. Storm Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964-2003 followed up to the end of 2006 Acta Oncol 49 5 2010 578 607
    • (2010) Acta Oncol , vol.49 , Issue.5 , pp. 578-607
    • Klint, Å.1    Engholm, G.2    Storm, H.H.3
  • 19
    • 77951219679 scopus 로고    scopus 로고
    • The Swedish Family-Cancer Database 2009: Prospects for histology-specific and immigrant studies
    • K. Hemminki, J. Ji, A. Brandt, S.M. Mousavi, and J. Sundquist The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies Int J Cancer 126 10 2010 2259 2267
    • (2010) Int J Cancer , vol.126 , Issue.10 , pp. 2259-2267
    • Hemminki, K.1    Ji, J.2    Brandt, A.3    Mousavi, S.M.4    Sundquist, J.5
  • 20
    • 84865563842 scopus 로고    scopus 로고
    • Comparability of cancer identification among Death Registry, Cancer Registry and Hospital Discharge Registry
    • J. Ji, K. Sundquist, J. Sundquist, and K. Hemminki Comparability of cancer identification among Death Registry, Cancer Registry and Hospital Discharge Registry Int J Cancer 131 9 2012 2085 2093
    • (2012) Int J Cancer , vol.131 , Issue.9 , pp. 2085-2093
    • Ji, J.1    Sundquist, K.2    Sundquist, J.3    Hemminki, K.4
  • 22
    • 84867117709 scopus 로고    scopus 로고
    • Cancer of unknown primary (CUP): Does cause of death and family history implicate hidden phenotypically changed primaries?
    • K. Hemminki, M. Bevier, J. Sundquist, and A. Hemminki Cancer of unknown primary (CUP): does cause of death and family history implicate hidden phenotypically changed primaries? Ann Oncol 23 10 2012 2720 2724
    • (2012) Ann Oncol , vol.23 , Issue.10 , pp. 2720-2724
    • Hemminki, K.1    Bevier, M.2    Sundquist, J.3    Hemminki, A.4
  • 23
    • 84871399411 scopus 로고    scopus 로고
    • Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries
    • K. Hemminki, M. Bevier, J. Sundquist, and A. Hemminki Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries Int J Cancer 132 2013 944 950
    • (2013) Int J Cancer , vol.132 , pp. 944-950
    • Hemminki, K.1    Bevier, M.2    Sundquist, J.3    Hemminki, A.4
  • 24
    • 79952392467 scopus 로고    scopus 로고
    • Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression
    • M.J. Bissell, and W.C. Hines Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression Nat Med 17 2011 2011 320 329
    • (2011) Nat Med , vol.17 , Issue.2011 , pp. 320-329
    • Bissell, M.J.1    Hines, W.C.2
  • 25
    • 79953151458 scopus 로고    scopus 로고
    • Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion
    • R.D. Schreiber, L.J. Old, and M.J. Smyth Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion Science 331 2011 1565 1570
    • (2011) Science , vol.331 , pp. 1565-1570
    • Schreiber, R.D.1    Old, L.J.2    Smyth, M.J.3
  • 26
    • 0031832733 scopus 로고    scopus 로고
    • Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer
    • D.C. Smith, R.L. Dunn, M.S. Strawderman, and K.J. Pienta Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer J Clin Oncol 16 5 1998 1835 1843
    • (1998) J Clin Oncol , vol.16 , Issue.5 , pp. 1835-1843
    • Smith, D.C.1    Dunn, R.L.2    Strawderman, M.S.3    Pienta, K.J.4
  • 27
    • 77952801723 scopus 로고    scopus 로고
    • Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006
    • Å. Klint, L. Tryggvadóttir, and F. Bray Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006 Acta Oncol 49 5 2010 632 643
    • (2010) Acta Oncol , vol.49 , Issue.5 , pp. 632-643
    • Klint, Å.1    Tryggvadóttir, L.2    Bray, F.3
  • 28
    • 33645834966 scopus 로고    scopus 로고
    • Metastatic patterns in adenocarcinoma
    • K.R. Hess, G.R. Varadhachary, and S.H. Taylor Metastatic patterns in adenocarcinoma Cancer 106 7 2006 1624 1633
    • (2006) Cancer , vol.106 , Issue.7 , pp. 1624-1633
    • Hess, K.R.1    Varadhachary, G.R.2    Taylor, S.H.3
  • 29
    • 22344449796 scopus 로고    scopus 로고
    • Brain metastasis of unknown primary: A diagnostic and therapeutic dilemma
    • K.S. Polyzoidis, G. Miliaras, and N. Pavlidis Brain metastasis of unknown primary: a diagnostic and therapeutic dilemma Cancer Treat Rev 31 4 2005 247 255
    • (2005) Cancer Treat Rev , vol.31 , Issue.4 , pp. 247-255
    • Polyzoidis, K.S.1    Miliaras, G.2    Pavlidis, N.3
  • 30
    • 76749135742 scopus 로고    scopus 로고
    • Modern multidisciplinary management of brain metastases
    • S.S. Thomas, and E.M. Dunbar Modern multidisciplinary management of brain metastases Curr Oncol Rep 12 1 2010 34 40
    • (2010) Curr Oncol Rep , vol.12 , Issue.1 , pp. 34-40
    • Thomas, S.S.1    Dunbar, E.M.2
  • 32
    • 77953632852 scopus 로고    scopus 로고
    • Surgical management and outcomes of colorectal cancer liver metastases
    • E.J. Morris, D. Forman, and J.D. Thomas Surgical management and outcomes of colorectal cancer liver metastases Br J Surg 97 7 2010 1110 1118
    • (2010) Br J Surg , vol.97 , Issue.7 , pp. 1110-1118
    • Morris, E.J.1    Forman, D.2    Thomas, J.D.3
  • 33
    • 83055179739 scopus 로고    scopus 로고
    • The current role of minimally invasive therapies in the management of liver tumors
    • H. Rempp, A. Boss, T. Helmberger, and P. Pereira The current role of minimally invasive therapies in the management of liver tumors Abdom Imaging 36 2011 635 647
    • (2011) Abdom Imaging , vol.36 , pp. 635-647
    • Rempp, H.1    Boss, A.2    Helmberger, T.3    Pereira, P.4
  • 34
    • 58949104455 scopus 로고    scopus 로고
    • Pulmonary metastasectomy: A survey of current practice amongst members of the European Society of Thoracic Surgeons
    • E. Internullo, S.D. Cassivi, D. Van Raemdonck, G. Friedel, and T. Treasure Pulmonary metastasectomy: a survey of current practice amongst members of the European Society of Thoracic Surgeons J Thorac Oncol 3 11 2008 1257 1266
    • (2008) J Thorac Oncol , vol.3 , Issue.11 , pp. 1257-1266
    • Internullo, E.1    Cassivi, S.D.2    Van Raemdonck, D.3    Friedel, G.4    Treasure, T.5
  • 35
    • 51149110316 scopus 로고    scopus 로고
    • Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: A multicentre Hellenic Cooperative Oncology Group phase II study
    • G. Pentheroudakis, E. Briasoulis, and H.P. Kalofonos Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study Acta Oncol 47 6 2008 1148 1155
    • (2008) Acta Oncol , vol.47 , Issue.6 , pp. 1148-1155
    • Pentheroudakis, G.1    Briasoulis, E.2    Kalofonos, H.P.3
  • 36
    • 0036984640 scopus 로고    scopus 로고
    • Role of angiogenesis in tumor growth and metastasis
    • J. Folkman Role of angiogenesis in tumor growth and metastasis Semin Oncol 29 6 Suppl. 16 2002 15 18
    • (2002) Semin Oncol , vol.29 , Issue.6 SUPPL. 16 , pp. 15-18
    • Folkman, J.1
  • 37
    • 34248995210 scopus 로고    scopus 로고
    • Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: The Minnie Pearl Cancer Research Network
    • J.D. Hainsworth, D.R. Spigel, C. Farley, D.S. Thompson, D.L. Shipley, and F.A. Greco Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: the Minnie Pearl Cancer Research Network J Clin Oncol 25 13 2007 1747 1752
    • (2007) J Clin Oncol , vol.25 , Issue.13 , pp. 1747-1752
    • Hainsworth, J.D.1    Spigel, D.R.2    Farley, C.3    Thompson, D.S.4    Shipley, D.L.5    Greco, F.A.6
  • 38
    • 79959570321 scopus 로고    scopus 로고
    • Socialstyrelsen The Swedish National Board of Health and Welfare
    • Socialstyrelsen. Cancer incidence in Sweden 2009. The Swedish National Board of Health and Welfare; 2010. Available from http://www.socialstyrelsen.se/ publikationer2010/2010-12-17.
    • (2010) Cancer Incidence in Sweden 2009


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.